Trial intelligence / Profile preview

Vitamin D3 supplementation in immunodeficient adults with frequent respiratory infections

2009-011758-16Phase 2Active

Sponsor
Karolinska University Hospital
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in upper respiratory infection (URI), Immunogenetic disorder and secondary immunodeficiency (SID) comparing Vitamin D3 (Vigantol Oil) with Placebo (2 arms). Primary endpoint: Frequency of airborne infections. Started Oct 2009; status: active.

02

Drugs

cholecalciferol
03

Conditions

upper respiratory infection (URI)Immunogenetic disordersecondary immunodeficiency (SID)

Beyond the preview

Go deeper on 2009-011758-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011758-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call